| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Artiva Biotherapeutics, Inc.
13D/A
ARTV · 04317A107
|
12.3% |
5/28/2026
Event 5/11/2026
|
||||
| GC Corp | 12.3% | |||||
| GC Cell Corporation | 3.3% | |||||
| Yong-Jun Huh | 12.3% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.